MDxHealth S.A. (MDXH) vs SCYNEXIS, Inc. (SCYX)
A side-by-side comparison of MDxHealth S.A. and SCYNEXIS, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDXH
MDxHealth S.A.
$0.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCYX
SCYNEXIS, Inc.
$4.84HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MDXH vs SCYX
growth of $100 · dividends reinvested · last 5yMDXH -95.0% (-45.1%/yr)SCYX -88.6% (-35.2%/yr)SCYX compounded faster over this window
MDXH SCYX
MDXH vs SCYX: by the numbers
- •MDXH is the larger company ($31M vs $30M market cap).
- •Both run net losses; MDXH's is the smaller (-31.07% vs -53.27% net margin).
- •MDXH grew revenue faster over the past five years (42.35% vs 9.78% CAGR).
Metrics side by side
Valuation
| Metric | MDXH | SCYX |
|---|---|---|
| P/S ratio | N/A | 1.58 |
| P/B ratio | N/A | 0.45 |
Profitability
| Metric | MDXH | SCYX |
|---|---|---|
| Gross margin | 59.74% | 100.00% |
| Operating margin | -14.28% | -78.03% |
| Net margin | -31.07% | -53.27% |
| ROE | N/A | -15.29% |
| ROIC | -15.35% | -32.68% |
Growth (annualized)
| Metric | MDXH | SCYX |
|---|---|---|
| Revenue CAGR (5Y) | 42.35% | 9.78% |
| Total return CAGR (5Y) | N/A | -34.13% |
Frequently asked
- Which has grown faster, MDXH or SCYX?
- Over the past five years, MDXH grew revenue faster — MDXH at a 42.35% CAGR versus SCYX at 9.78%.
Go deeper
Dig into the metrics
MDxHealth ROESCYNEXIS ROEMDxHealth operating marginSCYNEXIS operating marginMDxHealth revenue growthSCYNEXIS revenue growthMDxHealth free cash flowSCYNEXIS free cash flow
MDxHealth & SCYNEXIS appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.